Alerus Investment Advisors’s Novo Nordisk NVO Stock Holding History

Alerus Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2K	Buy	+84	New	+$2.25K	﹤0.01%	203

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Alerus Investment Advisors's NVO Position: Q1 2016 in Review

Alerus Investment Advisors opened a new position in Novo Nordisk (NVO) in Q1 2016: 84 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #203 among its holdings.

536 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

Alerus Investment Advisors held 84 shares of Novo Nordisk worth $2K as of Q1 2016.
Novo Nordisk was a new Alerus Investment Advisors position in Q1 2016.
Novo Nordisk made up ﹤0.01% of Alerus Investment Advisors's portfolio in Q1 2016, its #203 holding.
536 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.